__timestamp | ADMA Biologics, Inc. | Dr. Reddy's Laboratories Limited |
---|---|---|
Wednesday, January 1, 2014 | 9517014 | 12402000000 |
Thursday, January 1, 2015 | 7015946 | 17449000000 |
Friday, January 1, 2016 | 7688238 | 17834000000 |
Sunday, January 1, 2017 | 6229587 | 19551000000 |
Monday, January 1, 2018 | 3926120 | 18265000000 |
Tuesday, January 1, 2019 | 2343848 | 15607000000 |
Wednesday, January 1, 2020 | 5907013 | 15410000000 |
Friday, January 1, 2021 | 3646060 | 16541000000 |
Saturday, January 1, 2022 | 3613764 | 17482000000 |
Sunday, January 1, 2023 | 3300000 | 19381000000 |
Monday, January 1, 2024 | 22873000000 |
Igniting the spark of knowledge
In the competitive world of pharmaceuticals, innovation is key. Dr. Reddy's Laboratories Limited and ADMA Biologics, Inc. are two companies that have taken different paths in their investment in research and development (R&D) over the past decade. From 2014 to 2023, Dr. Reddy's consistently outspent ADMA Biologics, with R&D expenses peaking at nearly $19.4 billion in 2023, a staggering 1,900% more than ADMA's highest expenditure of approximately $9.5 million in 2014. This significant difference highlights Dr. Reddy's commitment to innovation, despite fluctuations in their annual spending. Meanwhile, ADMA Biologics has shown a more conservative approach, with a noticeable decline in R&D investment over the years. As we look to the future, the question remains: will ADMA Biologics increase its investment to compete with industry giants like Dr. Reddy's?
Comparing Innovation Spending: Amgen Inc. and Dr. Reddy's Laboratories Limited
R&D Spending Showdown: Gilead Sciences, Inc. vs Dr. Reddy's Laboratories Limited
Analyzing R&D Budgets: Regeneron Pharmaceuticals, Inc. vs ADMA Biologics, Inc.
Analyzing R&D Budgets: Dr. Reddy's Laboratories Limited vs Sarepta Therapeutics, Inc.
Analyzing R&D Budgets: Dr. Reddy's Laboratories Limited vs CymaBay Therapeutics, Inc.
R&D Spending Showdown: Dr. Reddy's Laboratories Limited vs ImmunityBio, Inc.
Comparing Innovation Spending: Dr. Reddy's Laboratories Limited and MorphoSys AG
Research and Development Investment: Dr. Reddy's Laboratories Limited vs Novavax, Inc.
Comparing Innovation Spending: Grifols, S.A. and ADMA Biologics, Inc.
Research and Development Investment: ADMA Biologics, Inc. vs Xenon Pharmaceuticals Inc.
Research and Development Investment: ADMA Biologics, Inc. vs Protagonist Therapeutics, Inc.
Research and Development: Comparing Key Metrics for ADMA Biologics, Inc. and Xencor, Inc.